Getting chips closer to the bedside

Diagnostic chips for bedside pharmacogenomics are not yet a reality. But Roche and Affymetrix Inc. took one step closer in June when they rolled out the first fruits of their partnership for clinical applications.

The AmpliChip CYP450 DNA microarray is based on AFFX's existing CYP450

Read the full 444 word article

How to gain access

Continue reading with a
two-week free trial.